Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Gabriella d’Ettorre, Claudio Maria Mastroianni, Giancarlo Ceccarelli et al.|Frontiers in Medicine|2020Cited by 218
Nox2 activation in Covid-19Francesco Violi, Claudio Maria Mastroianni, Maria Claudia Miele et al.|Redox Biology|2020Cited by 146
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort StudyGiancarlo Ceccarelli, Gabriella d’Ettorre, Cristian Borrazzo et al.|Frontiers in Nutrition|2021Cited by 78
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19Francesco Violi, Claudio Maria Mastroianni, Giancarlo Ceccarelli et al.|Circulation Research|2020Cited by 77
Is teicoplanin a complementary treatment option for COVID-19? The question remainsGiancarlo Ceccarelli, Mario Venditti, Francesco Alessandri et al.|International Journal of Antimicrobial Agents|2020Cited by 52